Thematic Investing ChannelInnovation Should Help Fuel Growth in This China Biotech ETFBy Ben HernandezApril 11, 2022
Beyond Basic Beta ChannelVaccine Stocks Lift Biotech ETFs as China Enters LockdownsBy Max ChenMarch 14, 2022
Nasdaq Investment Intelligence ChannelHow to Invest in Biotech in 2022By Karrie GordonDecember 15, 2021
Leveraged & Inverse ChannelDirexion Launches mRNA Technology-Focused ETFBy Karrie GordonDecember 9, 2021
Innovative ETFs ChannelModerna’s Omicron Booster Strategy Lifts Biotechnology ETFsBy Max ChenNovember 29, 2021
Innovative ETFs ChannelPfizer’s COVID-19 Pill Has Mixed Results for Healthcare ETFsBy Max ChenNovember 5, 2021
Innovative ETFs ChannelModerna Vaccine Is Granted Authorization in AustraliaBy Max ChenAugust 9, 2021
Innovative ETFs ChannelA Biotech ETF to Track Nasdaq’s Industry-Setting BenchmarkBy Max ChenJune 30, 2021
Modern Alpha ChannelThe BioRevolution: An ETF That Taps Into Nearly EverythingBy Max ChenJune 21, 2021
Multi-Factor ChannelInvesting for Tomorrow, Today: Exploring the Future of Health CareBy Max ChenApril 28, 2021
